Primary Care Pod podcast

New(ish) Drug for MACE Prevention

0:00
15:30
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Bempedoic Acid aka Nexletol has a new trial in NEJM that shows MACE reduction in very high risk patients (mostly secondary but some primary prevention).  NNT? NNH? Other trials on Bempedoic acid? Tune in and find out.

 

 

Flere episoder fra "Primary Care Pod"